Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Silverman who wrote (1905)	9/29/1997 7:46:00 PM
From: JOHN W.	of 6136

I think you are right, I am just paranoid. I am certain that the street.com will provide the same "exclusive" headlines if data is soon presented at the ICAAC that is quite contradictory to the study that they devoted almost the entire day to. Lets say data is presented over the next few days that is very positive regarding nelfinavir's cross resistance profile. I am positive the street.com will publish it in the same manner as today's coverage. We will soon see. I must be crazy to think there is anything that is remotely biased about thestreet.com article.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next